Hinge Health Debt to Equity Ratio 1971-1970 | HNGE

Current and historical debt to equity ratio values for Hinge Health (HNGE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Hinge Health debt/equity for the three months ending January 01, 1970 was 0.00.
Hinge Health Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.629B $0.000B
Hinge Health Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain and post-surgical rehabilitation. Hinge Health Inc. is based in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.313B 58.92
Tempus AI (TEM) United States $11.516B 0.00
Doximity (DOCS) United States $11.474B 53.12
Hims & Hers Health (HIMS) United States $11.060B 114.91
IRhythm Technologies (IRTC) United States $4.939B 0.00
Inspire Medical Systems (INSP) United States $3.905B 61.02
Privia Health (PRVA) United States $2.682B 183.33
Enovis (ENOV) United States $1.815B 10.12
Phreesia (PHR) United States $1.695B 0.00
Schrodinger (SDGR) United States $1.512B 0.00
10x Genomics (TXG) United States $1.444B 0.00
Clover Health Investments (CLOV) United States $1.405B 0.00
Azenta (AZTA) United States $1.400B 65.09
Omnicell (OMCL) United States $1.376B 24.28
Evolent Health (EVH) United States $1.310B 111.60
Claritev (CTEV) United States $0.716B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.485B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.452B 0.00
TruBridge (TBRG) United States $0.349B 773.33
Outset Medical (OM) United States $0.338B 0.00
Health Catalyst (HCAT) United States $0.265B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
EUDA Health Holdings (EUDA) Singapore $0.127B 0.00
American Well (AMWL) United States $0.124B 0.00
MDxHealth SA (MDXH) Belgium $0.109B 0.00
Pulmonx (LUNG) United States $0.105B 0.00
CareCloud (CCLD) United States $0.102B 3.89
111 (YI) China $0.060B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.051B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00